BOSTON, Sept. 28, 2026 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that the first three participants have all received their first dose of intranasal foralumab in the Phase 2a Healey ALS MyMatch BANYAN clinical trial.

The BANYAN Trial is evaluating intranasal foralumab in people living with amyotrophic lateral sclerosis (ALS). The study is sponsored by Tiziana Life Sciences and co-funded by the ALS Association through its Hoffman ALS Clinical Trial Awards Program. The trial is being conducted at the Healey & AMG Center (Boston, MA) and will be launched at The Les Turner ALS Center at Northwestern Medicine(Chicago, IL), University of Minnesota (Minneapolis, MN), and Nova Southeastern University (Davie, FL).

Trial Design

  • Participants: 44 individuals with early ALS (≤ 24 months since symptom onset), slow vital capacity (SVC) ≥ 65%, and neurofilament light chain (NfL) ≥ 40 pg/mL.
  • Randomization: 3:1 (active drug : placebo).
  • Duration: 12-week randomized, controlled treatment period followed by a 12-week active extension treatment period.
  • Primary Endpoint: Safety and tolerability of foralumab in patients with ALS.
  • Secondary and Exploratory Endpoints:
    1. Immune reconstitution reflected by regulatory T cells (Tregs) and T-cell subset profiling.
    2. Immunologic gene expression assessed via single-cell RNA sequencing of T-cell subpopulations.
    3. Changes in neurofilament light chain (NfL) levels.
    4. Changes in microglial activation measured by brain TSPO-PET/MRI scans.

On October 1, at 5:00pm ET,  the Sean M. Healey & AMG Center for Integrated ALS Care and Discovery at Mass General Brigham will host a community webinar with Tiziana to discuss the science behind foralumab. Register for the webinar here.

The trial (ClinicalTrials.gov identifier: NCT07688239) is led by Suma Babu, MBBS, MPH, Principal Investigator of Healey ALS MyMatch and Co-Director of the Neurological Clinical Research Institute (NCRI) at Mass General Brigham, and James Berry, MD, MPH, Director of the Mass General Brigham Neuroscience Institute Clinical Trials Center for Neurotherapeutics, Chief of the Division of ALS and Motor Neuron Diseases, and Director of the NCRI.

“This study serves as a significant step in advancing the development of foralumab for ALS,” said Dr. Babu. “The BANYAN trial is designed to answer important questions about foralumab, specifically, whether it has a biological effect on Treg pathway in ALS, as measured by biomarkers.”

“Dosing the first participants in the BANYAN Trial is a meaningful milestone for Tiziana and for the ALS community,” said Ivor Elrifi, Chief Executive Officer of Tiziana Life Sciences. “ALS is a devastating disease with urgent unmet medical need. Our intranasal foralumab represents a differentiated, non-invasive, and convenient approach designed to modulate neuroinflammation by inducing regulatory T cells that traffic to the central nervous system. We are deeply grateful for the partnership with the Healey & AMG Center, the ALS Association, the outstanding investigators, and trial sites, and most importantly, the people living with ALS and families who make this progress possible. We look forward to generating important biomarker and safety data that can help advance the field.”

About Foralumab

Foralumab, a fully human anti-CD3 monoclonal antibody, is a biological drug candidate that has been shown to stimulate T regulatory cells when dosed intranasally. At present, 14 patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) have been dosed in an open-label intermediate sized Expanded Access (EA) Program (NCT06802328) with either an improvement or stability of disease seen within 6 months in all patients. In addition, intranasal foralumab is currently being studied in a Phase 2a, randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial in patients with non-active secondary progressive multiple sclerosis (NCT06292923), as well as additional Phase 2 trials in AD and MSA.

Intranasal foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of neuroinflammatory and neurodegenerative human diseases.[1],[2]

About the Healey ALS MyMatch Program and BANYAN Trial:
Healey ALS MyMatch is reshaping ALS clinical research through biomarker-driven, personalized trial approaches. By integrating an emerging, comprehensive genetic and plasma biomarker pNFL, which was the basis of a recent accelerated approval for a genetic form of ALS, the program matches subgroups of individuals with ALS to experimental therapies based on their disease markers. The program consists of an ongoing series of early-phase clinical trials designed to deepen understanding of the biological effects of investigational products and to identify the optimal populations for future Phase 2/3 studies. Each trial in the program is named after a tree to symbolize hope and the deep scientific roots from which it grows, and careful thought went into designing the trial that balances scientific rigor with reducing participant and caregiver burden.

About Tiziana Life Sciences

Tiziana Life Sciences is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable alternative routes of immunotherapy. Tiziana’s innovative intranasal approach has the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery. Tiziana’s lead candidate, intranasal foralumab, which is the only fully human anti-CD3 mAb currently in clinical development, has demonstrated a favorable safety profile and clinical response in patients in studies to date. Tiziana’s technology for alternative routes of immunotherapy has been patented with several applications pending and is expected to allow for broad pipeline applications.

For more information about Tiziana Life Sciences and its innovative pipeline of therapies, please visit www.tizianalifesciences.com.

For further inquiries:

Tiziana Life Sciences Ltd
Paul Spencer, Business Development, and Investor Relations
+44 (0) 207 495 2379
email: info@tizianalifesciences.com

[1] https://www.pnas.org/doi/10.1073/pnas.2220272120

[2] https://www.pnas.org/doi/10.1073/pnas.2309221120

BOSTON, Sept. 28, 2026 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced that the first three participants have all received their first dose of intranasal foralumab in the Phase 2a Healey ALS MyMatch BANYAN clinical trial.

The BANYAN Trial is evaluating intranasal foralumab in people living with amyotrophic lateral sclerosis (ALS). The study is sponsored by Tiziana Life Sciences and co-funded by the ALS Association through its Hoffman ALS Clinical Trial Awards Program. The trial is being conducted at the Healey & AMG Center (Boston, MA) and will be launched at The Les Turner ALS Center at Northwestern Medicine(Chicago, IL), University of Minnesota (Minneapolis, MN), and Nova Southeastern University (Davie, FL).

Trial Design

  • Participants: 44 individuals with early ALS (≤ 24 months since symptom onset), slow vital capacity (SVC) ≥ 65%, and neurofilament light chain (NfL) ≥ 40 pg/mL.
  • Randomization: 3:1 (active drug : placebo).
  • Duration: 12-week randomized, controlled treatment period followed by a 12-week active extension treatment period.
  • Primary Endpoint: Safety and tolerability of foralumab in patients with ALS.
  • Secondary and Exploratory Endpoints:
    1. Immune reconstitution reflected by regulatory T cells (Tregs) and T-cell subset profiling.
    2. Immunologic gene expression assessed via single-cell RNA sequencing of T-cell subpopulations.
    3. Changes in neurofilament light chain (NfL) levels.
    4. Changes in microglial activation measured by brain TSPO-PET/MRI scans.

On October 1, at 5:00pm ET,  the Sean M. Healey & AMG Center for Integrated ALS Care and Discovery at Mass General Brigham will host a community webinar with Tiziana to discuss the science behind foralumab. Register for the webinar here.

The trial (ClinicalTrials.gov identifier: NCT07688239) is led by Suma Babu, MBBS, MPH, Principal Investigator of Healey ALS MyMatch and Co-Director of the Neurological Clinical Research Institute (NCRI) at Mass General Brigham, and James Berry, MD, MPH, Director of the Mass General Brigham Neuroscience Institute Clinical Trials Center for Neurotherapeutics, Chief of the Division of ALS and Motor Neuron Diseases, and Director of the NCRI.

“This study serves as a significant step in advancing the development of foralumab for ALS,” said Dr. Babu. “The BANYAN trial is designed to answer important questions about foralumab, specifically, whether it has a biological effect on Treg pathway in ALS, as measured by biomarkers.”

“Dosing the first participants in the BANYAN Trial is a meaningful milestone for Tiziana and for the ALS community,” said Ivor Elrifi, Chief Executive Officer of Tiziana Life Sciences. “ALS is a devastating disease with urgent unmet medical need. Our intranasal foralumab represents a differentiated, non-invasive, and convenient approach designed to modulate neuroinflammation by inducing regulatory T cells that traffic to the central nervous system. We are deeply grateful for the partnership with the Healey & AMG Center, the ALS Association, the outstanding investigators, and trial sites, and most importantly, the people living with ALS and families who make this progress possible. We look forward to generating important biomarker and safety data that can help advance the field.”

About Foralumab

Foralumab, a fully human anti-CD3 monoclonal antibody, is a biological drug candidate that has been shown to stimulate T regulatory cells when dosed intranasally. At present, 14 patients with Non-Active Secondary Progressive Multiple Sclerosis (na-SPMS) have been dosed in an open-label intermediate sized Expanded Access (EA) Program (NCT06802328) with either an improvement or stability of disease seen within 6 months in all patients. In addition, intranasal foralumab is currently being studied in a Phase 2a, randomized, double-blind, placebo-controlled, multicenter, dose-ranging trial in patients with non-active secondary progressive multiple sclerosis (NCT06292923), as well as additional Phase 2 trials in AD and MSA.

Intranasal foralumab is the only fully human anti-CD3 monoclonal antibody (mAb) currently in clinical development. Immunomodulation by intranasal foralumab represents a novel avenue for the treatment of neuroinflammatory and neurodegenerative human diseases.[1],[2]

About the Healey ALS MyMatch Program and BANYAN Trial:
Healey ALS MyMatch is reshaping ALS clinical research through biomarker-driven, personalized trial approaches. By integrating an emerging, comprehensive genetic and plasma biomarker pNFL, which was the basis of a recent accelerated approval for a genetic form of ALS, the program matches subgroups of individuals with ALS to experimental therapies based on their disease markers. The program consists of an ongoing series of early-phase clinical trials designed to deepen understanding of the biological effects of investigational products and to identify the optimal populations for future Phase 2/3 studies. Each trial in the program is named after a tree to symbolize hope and the deep scientific roots from which it grows, and careful thought went into designing the trial that balances scientific rigor with reducing participant and caregiver burden.

About Tiziana Life Sciences

Tiziana Life Sciences is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable alternative routes of immunotherapy. Tiziana’s innovative intranasal approach has the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery. Tiziana’s lead candidate, intranasal foralumab, which is the only fully human anti-CD3 mAb currently in clinical development, has demonstrated a favorable safety profile and clinical response in patients in studies to date. Tiziana’s technology for alternative routes of immunotherapy has been patented with several applications pending and is expected to allow for broad pipeline applications.

For more information about Tiziana Life Sciences and its innovative pipeline of therapies, please visit www.tizianalifesciences.com.

For further inquiries:

Tiziana Life Sciences Ltd
Paul Spencer, Business Development, and Investor Relations
+44 (0) 207 495 2379
email: info@tizianalifesciences.com

[1] https://www.pnas.org/doi/10.1073/pnas.2220272120

[2] https://www.pnas.org/doi/10.1073/pnas.2309221120

NVIDIA corporate headquarters

NVIDIA corporate headquarters
NVIDIA corporate headquarters

News Summary:

  • NVIDIA’s Board of Directors has authorized a $150 billion increase to the share repurchase program, raising the remaining total program to $235 billion.
  • This marks the largest share repurchase authorization increase in history.

SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) — NVIDIA today announced that its Board of Directors has authorized an additional $150 billion under the company’s existing share repurchase program, increasing the total remaining amount authorized to $235 billion.

The company expects to execute the total remaining program through fiscal year 2028.

“NVIDIA’s growth is being driven by a once-in-a-generation platform shift to AI and accelerated computing,” said Jensen Huang, founder and CEO of NVIDIA. “Our cash generation gives us the capacity to invest in the technologies that advance this transformation and return capital to shareholders. This authorization reflects our confidence in the long-term opportunity ahead.”

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the world leader in AI and accelerated computing.

For further information, contact:
Mylene Mangalindan
Corporate Communications
NVIDIA Corporation
press@nvidia.com  

Toshiya Hari
Investor Relations
NVIDIA Corporation
ir@nvidia.com

Certain statements in this press release including, but not limited to, statements as to: expectations with respect to NVIDIA’s share repurchase program, including execution timeline; NVIDIA’s growth driven by a once-in-a-generation platform shift to AI and accelerated computing; NVIDIA’s cash generation giving it the capacity to invest in the technologies that advance this transformation and return capital to shareholders; expectations with respect to the long-term opportunity ahead; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing products and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; NVIDIA’s ability to realize the potential benefits of business investments or acquisitions; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of reports filed with the SEC are posted on NVIDIA’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, and other NVIDIA product and service names are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries and regions. Other company, product, and service names may be trademarks of the respective companies with which they are associated.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/39454f98-f1a6-4f6a-b3ab-43fe63dad6e3

NVIDIA corporate headquarters

NVIDIA corporate headquarters
NVIDIA corporate headquarters

News Summary:

  • NVIDIA’s Board of Directors has authorized a $150 billion increase to the share repurchase program, raising the remaining total program to $235 billion.
  • This marks the largest share repurchase authorization increase in history.

SANTA CLARA, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) — NVIDIA today announced that its Board of Directors has authorized an additional $150 billion under the company’s existing share repurchase program, increasing the total remaining amount authorized to $235 billion.

The company expects to execute the total remaining program through fiscal year 2028.

“NVIDIA’s growth is being driven by a once-in-a-generation platform shift to AI and accelerated computing,” said Jensen Huang, founder and CEO of NVIDIA. “Our cash generation gives us the capacity to invest in the technologies that advance this transformation and return capital to shareholders. This authorization reflects our confidence in the long-term opportunity ahead.”

About NVIDIA
NVIDIA (NASDAQ: NVDA) is the world leader in AI and accelerated computing.

For further information, contact:
Mylene Mangalindan
Corporate Communications
NVIDIA Corporation
press@nvidia.com  

Toshiya Hari
Investor Relations
NVIDIA Corporation
ir@nvidia.com

Certain statements in this press release including, but not limited to, statements as to: expectations with respect to NVIDIA’s share repurchase program, including execution timeline; NVIDIA’s growth driven by a once-in-a-generation platform shift to AI and accelerated computing; NVIDIA’s cash generation giving it the capacity to invest in the technologies that advance this transformation and return capital to shareholders; expectations with respect to the long-term opportunity ahead; and other statements that are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the “safe harbor” created by those sections based on management’s beliefs and assumptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic and political conditions; NVIDIA’s reliance on third parties to manufacture, assemble, package and test NVIDIA’s products; the impact of technological development and competition; development of new products and technologies or enhancements to NVIDIA’s existing products and technologies; market acceptance of NVIDIA’s products or NVIDIA’s partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of NVIDIA’s products or technologies when integrated into systems; NVIDIA’s ability to realize the potential benefits of business investments or acquisitions; and changes in applicable laws and regulations, as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of reports filed with the SEC are posted on NVIDIA’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2026 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, and other NVIDIA product and service names are trademarks and/or registered trademarks of NVIDIA Corporation in the U.S. and other countries and regions. Other company, product, and service names may be trademarks of the respective companies with which they are associated.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/39454f98-f1a6-4f6a-b3ab-43fe63dad6e3

GXO appoints Dan Davis as President of Aerospace & Defense

Dan Davis brings decades of industry experience and military expertise to this newly created role at GXO.
Dan Davis brings decades of industry experience and military expertise to this newly created role at GXO.

GREENWICH, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced the appointment of Dan Davis as President of Aerospace & Defense, a newly created enterprise role focused on accelerating the Company’s growth and strengthening its position in one of its most strategic growth verticals. Davis joins GXO today, reporting to CEO Patrick Kelleher.

Aerospace & Defense represents one of the most significant growth opportunities for GXO, building on the company’s deep operational expertise and track record of serving complex, highly regulated industries around the world. In this role, Davis will lead GXO’s global Aerospace & Defense growth strategy to drive market development, customer acquisition, strategic partnerships and pipeline growth across the business.

“At GXO, we continue to invest in the leadership, capabilities and strategic focus needed to accelerate growth in the sectors where we see the greatest opportunity,” said GXO CEO Patrick Kelleher. “Aerospace & Defense is an increasingly important sector that requires a differentiated go-to-market engine. Dan brings a rare combination of military experience, industry expertise and commercial leadership that will help us deepen customer relationships, expand our capabilities and strengthen GXO’s position as a trusted partner for mission-critical supply chains.”

Davis joins GXO from FSI Defense, a FlightSafety International and Berkshire Hathaway company, where he served as President. In that role, he more than doubled the company’s growth pipeline while improving revenue, profitability and customer satisfaction. Previously, Davis spent fifteen years with Lockheed Martin working across multiple business areas in Program Management and Capture Management roles. A graduate of the United States Military Academy at West Point, he also served as a Field Artillery Officer in the U.S. Army.

Earlier this year, GXO took key strategic actions to strengthen its position in the defense sector. The company established a Defense Advisory Board, bringing together distinguished leaders with deep military expertise to provide strategic counsel and actionable insights on growth opportunities. GXO also joined Amentum, Accenture and A.P. Moller-Maersk as a founding member of Torus Defence Supply Chain, an alliance designed to help strengthen the future of the UK defense sector.

About GXO
GXO Logistics, Inc. (NYSE: GXO) is the world’s largest pure-play contract logistics provider and is positioned to capitalize on the rapid growth of ecommerce, automation and outsourcing. GXO has over 150,000 team members across more than 1,000 facilities, totaling more than 200 million square feet. The company serves the world’s leading blue-chip companies to solve complex logistics challenges with technologically advanced supply chain and ecommerce solutions, at scale and with speed. GXO corporate headquarters is in Greenwich, Connecticut. Visit GXO.com for more information and connect with GXO on LinkedIn, X, Facebook, Instagram and YouTube.

Media contacts

Matthew Schmidt 
+1 203-307-2809 
matt.schmidt@gxo.com

Kathleen Juviler
+1 203-921-9121
kathleen.juviler@gxo.com

Attachment

GXO appoints Dan Davis as President of Aerospace & Defense

Dan Davis brings decades of industry experience and military expertise to this newly created role at GXO.
Dan Davis brings decades of industry experience and military expertise to this newly created role at GXO.

GREENWICH, Conn., Sept. 28, 2026 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today announced the appointment of Dan Davis as President of Aerospace & Defense, a newly created enterprise role focused on accelerating the Company’s growth and strengthening its position in one of its most strategic growth verticals. Davis joins GXO today, reporting to CEO Patrick Kelleher.

Aerospace & Defense represents one of the most significant growth opportunities for GXO, building on the company’s deep operational expertise and track record of serving complex, highly regulated industries around the world. In this role, Davis will lead GXO’s global Aerospace & Defense growth strategy to drive market development, customer acquisition, strategic partnerships and pipeline growth across the business.

“At GXO, we continue to invest in the leadership, capabilities and strategic focus needed to accelerate growth in the sectors where we see the greatest opportunity,” said GXO CEO Patrick Kelleher. “Aerospace & Defense is an increasingly important sector that requires a differentiated go-to-market engine. Dan brings a rare combination of military experience, industry expertise and commercial leadership that will help us deepen customer relationships, expand our capabilities and strengthen GXO’s position as a trusted partner for mission-critical supply chains.”

Davis joins GXO from FSI Defense, a FlightSafety International and Berkshire Hathaway company, where he served as President. In that role, he more than doubled the company’s growth pipeline while improving revenue, profitability and customer satisfaction. Previously, Davis spent fifteen years with Lockheed Martin working across multiple business areas in Program Management and Capture Management roles. A graduate of the United States Military Academy at West Point, he also served as a Field Artillery Officer in the U.S. Army.

Earlier this year, GXO took key strategic actions to strengthen its position in the defense sector. The company established a Defense Advisory Board, bringing together distinguished leaders with deep military expertise to provide strategic counsel and actionable insights on growth opportunities. GXO also joined Amentum, Accenture and A.P. Moller-Maersk as a founding member of Torus Defence Supply Chain, an alliance designed to help strengthen the future of the UK defense sector.

About GXO
GXO Logistics, Inc. (NYSE: GXO) is the world’s largest pure-play contract logistics provider and is positioned to capitalize on the rapid growth of ecommerce, automation and outsourcing. GXO has over 150,000 team members across more than 1,000 facilities, totaling more than 200 million square feet. The company serves the world’s leading blue-chip companies to solve complex logistics challenges with technologically advanced supply chain and ecommerce solutions, at scale and with speed. GXO corporate headquarters is in Greenwich, Connecticut. Visit GXO.com for more information and connect with GXO on LinkedIn, X, Facebook, Instagram and YouTube.

Media contacts

Matthew Schmidt 
+1 203-307-2809 
matt.schmidt@gxo.com

Kathleen Juviler
+1 203-921-9121
kathleen.juviler@gxo.com

Attachment

Second Batch Order in Two Months Underscores Growing Value of CATL Partnership

Jinhua, China, Sept. 28, 2026 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (“Kandi” or the “Company”) (NASDAQ GS: KNDI), a global innovator in intelligent equipment and a technology-driven platform company, today announced that its wholly-owned subsidiary, China Battery Exchange (Zhejiang) Technology Co., Ltd. (“China Battery Exchange”), has secured a second batch procurement order for heavy-truck battery swap station equipment from QIJI Energy, a subsidiary of Contemporary Amperex Technology Co., Limited (“CATL”). The order follows just two months after the initial batch order placed in July 2026, highlighting the continued commercial development of the Company’s relationship with CATL.

China Battery Exchange’s cooperation with CATL began in August 2025, when the two companies signed a Framework Procurement Contract under which China Battery Exchange became part of CATL’s global supplier network and began coordinating CATL’s first order for a heavy-truck battery swap station, which was secured later that month. In January 2026, China Battery Exchange entered into a three-year strategic cooperation agreement to serve as a designated equipment supplier for QIJI Energy’s heavy-truck battery-swapping program. In July 2026, QIJI Energy placed its first batch procurement order under the strategic cooperation agreement, marking China Battery Exchange’s transition from product validation to commercial deployment. With its supplier relationship with CATL and approved-supplier status with QIJI Energy, China Battery Exchange is positioned to pursue additional equipment orders in connection with CATL’s heavy-truck battery-swapping program . 

China Battery Exchange’s Lin’an intelligent manufacturing facility commenced production in July 2026. With an expected annual production capacity of up to 200 battery swap stations, the facility is intended to support China Battery Exchange’s ability to fulfill existing and potential future orders from CATL and serve additional battery swap equipment customers.

Feng Chen, CEO of Kandi, commented, “We have received two batch orders within eight months of signing the QIJI Energy agreement, reflecting CATL’s continued confidence in our products and delivery capabilities as well as the commercial potential of this partnership. We will continue to advance product development, expand production capacity and improve delivery efficiency to capture opportunities in the emerging heavy-truck battery swap market and establish battery swap equipment as a new growth engine for Kandi.”

Safe Harbor Statement

This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on the SEC’s website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

About Kandi Technologies Group, Inc.

Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) is a global innovator in intelligent equipment and a technology-driven platform company. It leverages technological innovation, a global supply chain, and advanced manufacturing to transform industries and expand real-world applications, bringing technology closer to people’s everyday lives. Guided by a “one core, two growth engines” framework, the Company anchors its business in all-domain intelligent vehicles, with battery swapping equipment and intelligent robotics as two growth pillars. Driven by its mission to bring joy to daily life, Kandi Technologies fosters shared success and sustainable, long-term growth through open collaboration and mutually beneficial partnerships, creating enduring industrial and societal value while building a globally respected brand.

For more information, please visit ir.kandigroup.com. The Company provides important updates on its website.

For investor and media inquiries, please contact:

Kandi Technologies Group, Inc.
Kewa Luo
Tel: +1 (212) 551-3610
Email: IR@kandigroup.com

Piacente Financial Communications
Brandi Piacente
Tel: +86-10-6508-0677
Email: Kandi@thepiacentegroup.com

Second Batch Order in Two Months Underscores Growing Value of CATL Partnership

Jinhua, China, Sept. 28, 2026 (GLOBE NEWSWIRE) — Kandi Technologies Group, Inc. (“Kandi” or the “Company”) (NASDAQ GS: KNDI), a global innovator in intelligent equipment and a technology-driven platform company, today announced that its wholly-owned subsidiary, China Battery Exchange (Zhejiang) Technology Co., Ltd. (“China Battery Exchange”), has secured a second batch procurement order for heavy-truck battery swap station equipment from QIJI Energy, a subsidiary of Contemporary Amperex Technology Co., Limited (“CATL”). The order follows just two months after the initial batch order placed in July 2026, highlighting the continued commercial development of the Company’s relationship with CATL.

China Battery Exchange’s cooperation with CATL began in August 2025, when the two companies signed a Framework Procurement Contract under which China Battery Exchange became part of CATL’s global supplier network and began coordinating CATL’s first order for a heavy-truck battery swap station, which was secured later that month. In January 2026, China Battery Exchange entered into a three-year strategic cooperation agreement to serve as a designated equipment supplier for QIJI Energy’s heavy-truck battery-swapping program. In July 2026, QIJI Energy placed its first batch procurement order under the strategic cooperation agreement, marking China Battery Exchange’s transition from product validation to commercial deployment. With its supplier relationship with CATL and approved-supplier status with QIJI Energy, China Battery Exchange is positioned to pursue additional equipment orders in connection with CATL’s heavy-truck battery-swapping program . 

China Battery Exchange’s Lin’an intelligent manufacturing facility commenced production in July 2026. With an expected annual production capacity of up to 200 battery swap stations, the facility is intended to support China Battery Exchange’s ability to fulfill existing and potential future orders from CATL and serve additional battery swap equipment customers.

Feng Chen, CEO of Kandi, commented, “We have received two batch orders within eight months of signing the QIJI Energy agreement, reflecting CATL’s continued confidence in our products and delivery capabilities as well as the commercial potential of this partnership. We will continue to advance product development, expand production capacity and improve delivery efficiency to capture opportunities in the emerging heavy-truck battery swap market and establish battery swap equipment as a new growth engine for Kandi.”

Safe Harbor Statement

This press release contains certain statements that may include “forward-looking statements.” All statements other than statements of historical fact included herein are “forward-looking statements.” These forward-looking statements are often identified by the use of forward-looking terminology such as “believes,” “expects” or similar expressions, involving known and unknown risks and uncertainties. Although the Company believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including the risk factors discussed in the Company’s periodic reports that are filed with the Securities and Exchange Commission and available on the SEC’s website (http://www.sec.gov). All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these risk factors. Other than as required under the applicable securities laws, the Company does not assume a duty to update these forward-looking statements.

About Kandi Technologies Group, Inc.

Kandi Technologies Group, Inc. (NASDAQ GS: KNDI) is a global innovator in intelligent equipment and a technology-driven platform company. It leverages technological innovation, a global supply chain, and advanced manufacturing to transform industries and expand real-world applications, bringing technology closer to people’s everyday lives. Guided by a “one core, two growth engines” framework, the Company anchors its business in all-domain intelligent vehicles, with battery swapping equipment and intelligent robotics as two growth pillars. Driven by its mission to bring joy to daily life, Kandi Technologies fosters shared success and sustainable, long-term growth through open collaboration and mutually beneficial partnerships, creating enduring industrial and societal value while building a globally respected brand.

For more information, please visit ir.kandigroup.com. The Company provides important updates on its website.

For investor and media inquiries, please contact:

Kandi Technologies Group, Inc.
Kewa Luo
Tel: +1 (212) 551-3610
Email: IR@kandigroup.com

Piacente Financial Communications
Brandi Piacente
Tel: +86-10-6508-0677
Email: Kandi@thepiacentegroup.com

Warehousing Services Rose to 41.5% of Total Revenue as Customer Fulfillment Shifted Toward Platform-Bundled Programs; Gross Profit Improved by $3.4 Million; Convertible Notes Fully Settled and Total Liabilities Reduced by $22.4 Million

WALNUT, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today reported financial results for its fiscal year ended June 30, 2026 (“fiscal 2026”).

Total revenue for fiscal 2026 was $185.8 million, compared with $190.4 million in the fiscal year ended June 30,2025 (“fiscal 2025”), as a 21.9% increase in warehousing services revenue to $77.1 million was offset by a 14.5% decrease in transportation services revenue to $108.6 million. Gross profit was $0.4 million, compared with a gross loss of $3.0 million in the prior year. Net loss was $20.9 million, or $(0.47) per basic and diluted share, compared with a net loss of $15.3 million, or $(0.37) per share, in fiscal 2025. Cash, cash equivalents, and restricted cash totaled $6.5 million at June 30, 2026.

Fiscal 2026 Financial Highlights (Year Ended June 30, 2026, Compared with Year Ended June 30, 2025)

  • Total revenue of $185.8 million, a decrease of $4.6 million, or 2.4%, from $190.4 million.
  • Warehousing services revenue increased by $13.9 million, or 21.9%, to $77.1 million from $63.3 million, representing 41.5% of total revenue, up from 33.2%.
  • Transportation services revenue decreased by $18.4 million, or 14.5%, to $108.6 million from $127.0 million.
  • Cost of service decreased by $8.0 million, or 4.1%, to $185.4 million from $193.4 million, led by an $18.2 million, or 16.1%, reduction in freight expenses.
  • Gross profit of $0.4 million, or 0.2% of revenue, compared with a gross loss of $3.0 million, or negative 1.6% of revenue.
  • General and administrative expenses of $22.0 million, compared with $14.7 million, primarily reflecting $6.2 million of additional rental expense for leased warehouse facilities that remained partly underutilized during ramp-up, and a $1.1 million increase in credit loss expense.
  • Loss from operations of $21.5 million, compared with $17.7 million.
  • Net loss of $20.9 million, or $(0.47) per basic and diluted share, compared with a net loss of $15.3 million, or $(0.37) per share. Fiscal 2025 results included a $1.6 million income tax recovery; no tax recovery was recorded in fiscal 2026.
  • Active customer base of 525 at June 30, 2026, compared with 505 at June 30, 2025. Customers based in the People’s Republic of China accounted for approximately 78% of revenue, down from approximately 84%.
  • Convertible notes outstanding reduced to nil from $5.3 million at June 30, 2025; total liabilities decreased by $22.4 million to $122.7 million.
  • Cash, cash equivalents, and restricted cash of $6.5 million at June 30, 2026, compared with $13.6 million at June 30, 2025.

Management Commentary
“Fiscal 2026 moved Armlogi’s revenue mix toward the services we deliver inside our own four walls,” said Aidy Chou, Chairman and Chief Executive Officer of Armlogi. “Warehousing services grew 21.9% and now generate more than 40% of our revenue. The Ontario, California facility we opened in fiscal 2025 became the primary California distribution point for several of our larger customers in December 2025 and finished the year as our third-highest revenue-generating warehouse in the state. Transportation revenue declined because more of our customers ship through fulfillment programs bundled by the selling platforms, which reduces the freight we resell but keeps the warehousing relationship with us. Importantly, we closed fiscal 2026 with no convertible notes outstanding and $22.4 million less in total liabilities than a year earlier, and our remaining obligations are predominantly the lease obligations on a warehousing network that we continue to develop. Our work in fiscal 2027 is to fill the capacity we have already leased, execute the cost-optimization plan we have set out, and put in place the capital structure the business needs to complete this transition.”

Fiscal 2026 Operating Review
Revenue: Warehousing services revenue grew to $77.1 million from $63.3 million. Warehouse operations expanded significantly in Texas and Illinois, markets the Company entered shortly before or during fiscal 2025, and the Ontario, California warehouse expanded during fiscal 2025. The Company also grew its Temu and TikTok customer segments, which typically incur higher-than-average warehousing service charges per order than traditional customers.

Transportation services revenue declined to $108.6 million from $127.0 million, as a smaller proportion of order volume came from traditional customers shipping individual items directly to consumers. More of these customers now transfer inventory in bulk to Amazon warehouses for sale through the Fulfillment by Amazon program, and more customers are arranging their own outbound delivery rather than purchasing a transportation service option from the Company. Other services revenue, consisting primarily of customs brokerage, was $0.1 million in fiscal 2025 and fiscal 2026.

Cost of service and gross profit: Cost of service decreased to $185.4 million from $193.4 million. Freight expenses decreased by $18.2 million, or 16.1%, to $95.0 million due to lower freight volume. Temporary labor expenses increased $13.1 million, or 75.1%, to $30.6 million, while salary and benefits decreased by $1.1 million, or 11.1%, to $9.1 million, as the Georgia, Illinois, and Ontario, California warehouses, which are staffed primarily with temporary labor, ramped up toward capacity and the Company carried out a significant inventory reorganization across its California warehouses. Rental expense within cost of service decreased $1.7 million, or 4.3%, to $36.6 million; occupancy costs for warehouse capacity in pre-operational setup and ramp-up were recorded in general and administrative expenses rather than cost of service, as that capacity did not yet support revenue-generating activity. Gross profit was $0.4 million, or 0.2% of revenue, compared with a gross loss of $3.0 million, or negative 1.6% of revenue, in fiscal 2025.

General and administrative expenses: General and administrative expenses increased $7.3 million, or 49.7%, to $22.0 million from $14.7 million. Rental expense recorded in general and administrative expenses increased $6.2 million to $8.8 million, reflecting the occupancy costs of additional leased warehouse facilities, a portion of which remained underutilized during the year. Credit loss expense increased $1.1 million to $1.4 million, reflecting a higher allowance for credit losses on accounts receivable, other receivables, and loan receivables. Professional fees, office expenses, salaries, and benefits were essentially unchanged year over year.

Other income and income taxes: Total other income, net, was $0.7 million, compared with $0.8 million, reflecting lower rental income from sublease arrangements, partly offset by the absence of the $1.2 million loss on debt extinguishment recorded in fiscal 2025. Fiscal 2025 results included a $1.6 million income tax recovery; the Company recorded no income tax provision or recovery in fiscal 2026.

Net loss: Net loss was $20.9 million, or $(0.47) per basic and diluted share on 44,691,736 weighted average shares outstanding, compared with a net loss of $15.3 million, or $(0.37) per share on 41,808,909 weighted average shares outstanding, in fiscal 2025.

Balance Sheet and Liquidity
At June 30, 2026, cash and cash equivalents were $2.2 million, and restricted cash, held as collateral for standby letters of credit supporting certain of the Company’s leases, was $4.3 million, for total cash, cash equivalents, and restricted cash of $6.5 million, compared with $13.6 million at June 30, 2025. Net cash used in operating activities was $5.1 million, compared with net cash provided by operating activities of $1.5 million in fiscal 2025. Investing activities provided $0.7 million, as $4.8 million in loan repayments received exceeded $1.8 million in property and equipment purchases and $2.4 million in loans extended to third parties. Financing activities used $2.6 million, consisting of $2.0 million of cash repayments of convertible notes and $0.6 million of finance lease payments.

During fiscal 2026, the Company settled the entire balance of the convertible notes issued under its Standby Equity Purchase Agreement through $2.0 million of cash repayments and the conversion of $3.8 million into 3,192,145 shares of common stock in September 2025. Convertible notes outstanding were nil as of June 30, 2026, compared with $5.3 million as of June 30, 2025. Total liabilities decreased to $122.7 million from $145.1 million, primarily reflecting a $17.6 million reduction in operating lease liabilities and the settlement of the convertible notes. Total stockholders’ equity was $8.0 million at June 30, 2026.

Fiscal 2027 Priorities
The Company’s operating priorities for fiscal 2027 are to raise utilization across its eleven-warehouse network, particularly the Georgia, Illinois, Texas, and Ontario, California facilities added or expanded over the past two fiscal years; to continue diversifying its customer base across e-commerce platforms and geographies, including Southeast Asia and Mexico, while growing higher-value warehousing relationships; to execute the cost-optimization plan described above; and to continue evaluating targeted investments in supply-chain technology and warehouse automation, including conveyor systems, as part of its effort to lower unit costs.

About Armlogi Holding Corp.
Armlogi Holding Corp., based in Walnut, CA, is a U.S.-based warehousing and logistics service provider offering a comprehensive suite of supply-chain solutions, including warehouse management and order fulfillment. The Company caters to cross-border e-commerce merchants seeking to establish U.S. market warehouses. With 11 warehouses totaling approximately 3.8 million square feet, the Company offers one-stop warehousing and logistics services. The Company’s warehouses are equipped with facilities and technology to handle and store large, bulky items. For more information, please visit www.armlogi.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, our representatives may from time to time make forward-looking statements, orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our ability to achieve or maintain profitability; our business prospects and opportunities; and the expected benefits of our operational initiatives, including raising warehouse utilization, executing our cost-optimization plan, diversifying our customer base, and evaluating investments in supply-chain technology and warehouse automation. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to raise utilization across our warehouse network and achieve the anticipated cost efficiencies; the concentration of our revenue from customers based in the People’s Republic of China and the impact of changes in U.S.-China trade relations, tariffs, and geopolitical conditions; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; changes in demand for our services; our dependence on third-party logistics service providers; and the going concern considerations described in our financial statements. These and other factors, including those described in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. Forward-looking statements speak only as of the date of this press release, and except as required by law, we undertake no obligation to update or revise any forward-looking statement publicly. The forward-looking events discussed in this press release and other statements made from time to time by our representatives or us may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions described above and in our SEC filings.

Company Contact:
info@armlogi.com

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

**Tables Follow**

 
ARMLOGI HOLDING CORP.
CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2026 AND 2025
(US$, except share data, or otherwise noted)
     
  June 30, 2026 June 30, 2025
  US$ US$
Assets    
Current assets    
Cash and cash equivalents 2,217,199   9,190,277
Accounts receivable and other receivables, net of credit loss allowance of $1,273,113 and $594,869 at June 30, 2026 and 2025, respectively 15,770,917   22,207,500
Other current assets, net of credit loss allowance of $266,953 and $nil 30,182   998,925
Prepaid expenses 926,375   1,375,646
Loan receivables, net of credit loss allowance of $453,449 and $nil 1,059,612   3,893,563
Total current assets 20,004,285   37,665,911
Non-current assets    
Restricted cash 4,325,148   4,387,550
Property and equipment, net 10,775,190   11,259,820
Intangible assets, net 13,148   54,627
Right-of-use assets – operating leases 93,905,576   115,361,185
Right-of-use assets – finance leases 1,092,157   745,547
Other non-current assets 631,934   739,555
Total assets 130,747,438   170,214,195
     
Liabilities and Stockholders’ Equity    
Current liabilities    
Accounts payable and accrued liabilities 9,994,669   9,604,783
Contract liabilities 515,997   939,097
Accrued payroll liabilities 441,503   283,150
Convertible notes —   5,292,749
Operating lease liabilities – current 34,028,979   29,280,907
Finance lease liabilities – current 641,734   386,327
Total current liabilities 45,622,882   45,787,013
Non-current liabilities    
Operating lease liabilities – non-current 76,606,696   98,939,552
Finance lease liabilities – non-current 502,442   397,692
Total liabilities 122,732,020   145,124,257
     
Stockholders’ equity    
Common stock, US$0.00001 par value, 100,000,000 shares authorized, 45,443,079 and 42,250,934 shares issued and outstanding as of June 30, 2026 and 2025, respectively 454   422
Additional paid-in capital 20,468,826   16,668,858
Retained earnings (accumulated deficit) (12,453,862 ) 8,420,658
Total stockholders’ equity 8,015,418   25,089,938
Total liabilities and stockholders’ equity 130,747,438   170,214,195

ARMLOGI HOLDING CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
FOR THE YEARS ENDED JUNE 30, 2026 AND 2025
(US$, except share data, or otherwise noted)
     
  Year Ended June 30, 2026 Year Ended June 30, 2025
  US$ US$
Revenue 185,835,053   190,408,258  
Costs of service 185,410,217   193,408,827  
Gross profit (loss) 424,836   (3,000,569 )
     
Operating costs and expenses:    
General and administrative 21,969,387   14,675,543  
Total operating costs and expenses 21,969,387   14,675,543  
     
Loss from operations (21,544,551 ) (17,676,112 )
     
Other (income) expenses:    
Other income, net (1,215,885 ) (2,714,344 )
Loss on debt extinguishment —   1,192,431  
Gain (loss) on disposal of assets (104,061 ) 43,625  
Finance costs 649,915   714,352  
Total other income (670,031 ) (763,936 )
     
Loss before provision for income taxes (20,874,520 ) (16,912,176 )
     
Current income tax recovery —   (26,954 )
Deferred income tax recovery —   (1,536,455 )
Total income tax recovery —   (1,563,409 )
Net loss (20,874,520 ) (15,348,767 )
Total comprehensive loss (20,874,520 ) (15,348,767 )
     
Basic and diluted net loss per share (0.47 ) (0.37 )
Weighted average number of shares of common stock – basic and diluted 44,691,736   41,808,909  

ARMLOGI HOLDING CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED JUNE 30, 2026 AND 2025
(US$, except share data, or otherwise noted)
     
  Year Ended June 30, 2026 Year Ended June 30, 2025
  US$ US$
Cash flows from operating activities:    
Net loss (20,874,520 ) (15,348,767 )
Adjustments for items not affecting cash:    
Net (gain) loss from disposal of fixed assets (104,061 ) 43,625  
Depreciation of property and equipment and right-of-use finance lease assets 3,503,493   2,931,993  
Amortization 41,479   38,081  
Non-cash operating lease expense 3,891,672   7,536,058  
Current estimated credit loss 1,398,646   275,610  
Loss on debt extinguishment —   1,192,431  
Accretion of convertible note 527,251   617,845  
Deferred income taxes recovery —   (1,536,455 )
Interest income 20,503   (144,501 )
Changes in operating assets and liabilities:    
Accounts receivable and other receivables 5,758,337   2,981,935  
Other current assets 701,791   625,686  
Prepaid expenses 449,271   (246,211 )
Other non-current assets 107,621   (28,000 )
Accounts payable and accrued liabilities (269,504 ) 2,102,444  
Income tax payable —   (57,589 )
Contract liabilities (423,100 ) 662,634  
Accrued payroll liabilities 158,353   (122,100 )
Net changes in derecognized ROU and operating lease liability (20,847 ) (63,874 )
Net cash (used in) provided by operating activities (5,133,615 ) 1,460,845  
     
Cash flows from investing activities:    
Purchase of property and equipment (1,842,391 ) (2,889,928 )
Proceeds from disposal of property and equipment 191,161   48,000  
Loans extended to third parties (2,400,000 ) (1,000,000 )
Proceeds from loan repayments 4,760,000   2,036,705  
Net cash provided by (used in) investing activities 708,770   (1,805,223 )
     
Cash flows from financing activities:    
Lending to related parties —   (350,209 )
Repayments of finance lease liabilities (590,635 ) (360,443 )
Repayment of commitment payable —   (150,000 )
Repayment of convertible notes pursuant to SEPA (2,020,000 ) (3,260,000 )
Proceeds from convertible notes —   8,092,473  
Net cash (used in) provided by financing activities (2,610,635 ) 3,971,821  
     
Net (decrease) increase in cash and cash equivalents and restricted cash (7,035,480 ) 3,627,443  
Cash and cash equivalents and restricted cash, beginning of year 13,577,827   9,950,384  
Cash and cash equivalents and restricted cash, end of year 6,542,347   13,577,827  
     
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents 2,217,199   9,190,277  
Restricted cash – non-current 4,325,148   4,387,550  
Total cash and cash equivalents and restricted cash shown in the consolidated balance sheets 6,542,347   13,577,827  
     
Supplemental disclosure of cash flows information:    
Cash paid for income tax —   (122,248 )
Cash paid for interest —   (96,507 )
     
Non-cash transactions:    
Increase (decrease) in right-of-use assets due to remeasurement of lease terms 63,896   (1,148,456 )
Right-of-use assets acquired in exchange for operating lease liabilities 4,605,476   27,857,474  
Right-of-use assets acquired in exchange for finance lease liabilities 950,792   819,155  
Shares issued to settle commitment fee —   250,000  
Shares issued upon conversion of convertible notes issued pursuant to SEPA 3,800,000   950,000  

Warehousing Services Rose to 41.5% of Total Revenue as Customer Fulfillment Shifted Toward Platform-Bundled Programs; Gross Profit Improved by $3.4 Million; Convertible Notes Fully Settled and Total Liabilities Reduced by $22.4 Million

WALNUT, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) — Armlogi Holding Corp. (“Armlogi” or the “Company”) (Nasdaq: BTOC), a U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions related to warehouse management and order fulfillment, today reported financial results for its fiscal year ended June 30, 2026 (“fiscal 2026”).

Total revenue for fiscal 2026 was $185.8 million, compared with $190.4 million in the fiscal year ended June 30,2025 (“fiscal 2025”), as a 21.9% increase in warehousing services revenue to $77.1 million was offset by a 14.5% decrease in transportation services revenue to $108.6 million. Gross profit was $0.4 million, compared with a gross loss of $3.0 million in the prior year. Net loss was $20.9 million, or $(0.47) per basic and diluted share, compared with a net loss of $15.3 million, or $(0.37) per share, in fiscal 2025. Cash, cash equivalents, and restricted cash totaled $6.5 million at June 30, 2026.

Fiscal 2026 Financial Highlights (Year Ended June 30, 2026, Compared with Year Ended June 30, 2025)

  • Total revenue of $185.8 million, a decrease of $4.6 million, or 2.4%, from $190.4 million.
  • Warehousing services revenue increased by $13.9 million, or 21.9%, to $77.1 million from $63.3 million, representing 41.5% of total revenue, up from 33.2%.
  • Transportation services revenue decreased by $18.4 million, or 14.5%, to $108.6 million from $127.0 million.
  • Cost of service decreased by $8.0 million, or 4.1%, to $185.4 million from $193.4 million, led by an $18.2 million, or 16.1%, reduction in freight expenses.
  • Gross profit of $0.4 million, or 0.2% of revenue, compared with a gross loss of $3.0 million, or negative 1.6% of revenue.
  • General and administrative expenses of $22.0 million, compared with $14.7 million, primarily reflecting $6.2 million of additional rental expense for leased warehouse facilities that remained partly underutilized during ramp-up, and a $1.1 million increase in credit loss expense.
  • Loss from operations of $21.5 million, compared with $17.7 million.
  • Net loss of $20.9 million, or $(0.47) per basic and diluted share, compared with a net loss of $15.3 million, or $(0.37) per share. Fiscal 2025 results included a $1.6 million income tax recovery; no tax recovery was recorded in fiscal 2026.
  • Active customer base of 525 at June 30, 2026, compared with 505 at June 30, 2025. Customers based in the People’s Republic of China accounted for approximately 78% of revenue, down from approximately 84%.
  • Convertible notes outstanding reduced to nil from $5.3 million at June 30, 2025; total liabilities decreased by $22.4 million to $122.7 million.
  • Cash, cash equivalents, and restricted cash of $6.5 million at June 30, 2026, compared with $13.6 million at June 30, 2025.

Management Commentary
“Fiscal 2026 moved Armlogi’s revenue mix toward the services we deliver inside our own four walls,” said Aidy Chou, Chairman and Chief Executive Officer of Armlogi. “Warehousing services grew 21.9% and now generate more than 40% of our revenue. The Ontario, California facility we opened in fiscal 2025 became the primary California distribution point for several of our larger customers in December 2025 and finished the year as our third-highest revenue-generating warehouse in the state. Transportation revenue declined because more of our customers ship through fulfillment programs bundled by the selling platforms, which reduces the freight we resell but keeps the warehousing relationship with us. Importantly, we closed fiscal 2026 with no convertible notes outstanding and $22.4 million less in total liabilities than a year earlier, and our remaining obligations are predominantly the lease obligations on a warehousing network that we continue to develop. Our work in fiscal 2027 is to fill the capacity we have already leased, execute the cost-optimization plan we have set out, and put in place the capital structure the business needs to complete this transition.”

Fiscal 2026 Operating Review
Revenue: Warehousing services revenue grew to $77.1 million from $63.3 million. Warehouse operations expanded significantly in Texas and Illinois, markets the Company entered shortly before or during fiscal 2025, and the Ontario, California warehouse expanded during fiscal 2025. The Company also grew its Temu and TikTok customer segments, which typically incur higher-than-average warehousing service charges per order than traditional customers.

Transportation services revenue declined to $108.6 million from $127.0 million, as a smaller proportion of order volume came from traditional customers shipping individual items directly to consumers. More of these customers now transfer inventory in bulk to Amazon warehouses for sale through the Fulfillment by Amazon program, and more customers are arranging their own outbound delivery rather than purchasing a transportation service option from the Company. Other services revenue, consisting primarily of customs brokerage, was $0.1 million in fiscal 2025 and fiscal 2026.

Cost of service and gross profit: Cost of service decreased to $185.4 million from $193.4 million. Freight expenses decreased by $18.2 million, or 16.1%, to $95.0 million due to lower freight volume. Temporary labor expenses increased $13.1 million, or 75.1%, to $30.6 million, while salary and benefits decreased by $1.1 million, or 11.1%, to $9.1 million, as the Georgia, Illinois, and Ontario, California warehouses, which are staffed primarily with temporary labor, ramped up toward capacity and the Company carried out a significant inventory reorganization across its California warehouses. Rental expense within cost of service decreased $1.7 million, or 4.3%, to $36.6 million; occupancy costs for warehouse capacity in pre-operational setup and ramp-up were recorded in general and administrative expenses rather than cost of service, as that capacity did not yet support revenue-generating activity. Gross profit was $0.4 million, or 0.2% of revenue, compared with a gross loss of $3.0 million, or negative 1.6% of revenue, in fiscal 2025.

General and administrative expenses: General and administrative expenses increased $7.3 million, or 49.7%, to $22.0 million from $14.7 million. Rental expense recorded in general and administrative expenses increased $6.2 million to $8.8 million, reflecting the occupancy costs of additional leased warehouse facilities, a portion of which remained underutilized during the year. Credit loss expense increased $1.1 million to $1.4 million, reflecting a higher allowance for credit losses on accounts receivable, other receivables, and loan receivables. Professional fees, office expenses, salaries, and benefits were essentially unchanged year over year.

Other income and income taxes: Total other income, net, was $0.7 million, compared with $0.8 million, reflecting lower rental income from sublease arrangements, partly offset by the absence of the $1.2 million loss on debt extinguishment recorded in fiscal 2025. Fiscal 2025 results included a $1.6 million income tax recovery; the Company recorded no income tax provision or recovery in fiscal 2026.

Net loss: Net loss was $20.9 million, or $(0.47) per basic and diluted share on 44,691,736 weighted average shares outstanding, compared with a net loss of $15.3 million, or $(0.37) per share on 41,808,909 weighted average shares outstanding, in fiscal 2025.

Balance Sheet and Liquidity
At June 30, 2026, cash and cash equivalents were $2.2 million, and restricted cash, held as collateral for standby letters of credit supporting certain of the Company’s leases, was $4.3 million, for total cash, cash equivalents, and restricted cash of $6.5 million, compared with $13.6 million at June 30, 2025. Net cash used in operating activities was $5.1 million, compared with net cash provided by operating activities of $1.5 million in fiscal 2025. Investing activities provided $0.7 million, as $4.8 million in loan repayments received exceeded $1.8 million in property and equipment purchases and $2.4 million in loans extended to third parties. Financing activities used $2.6 million, consisting of $2.0 million of cash repayments of convertible notes and $0.6 million of finance lease payments.

During fiscal 2026, the Company settled the entire balance of the convertible notes issued under its Standby Equity Purchase Agreement through $2.0 million of cash repayments and the conversion of $3.8 million into 3,192,145 shares of common stock in September 2025. Convertible notes outstanding were nil as of June 30, 2026, compared with $5.3 million as of June 30, 2025. Total liabilities decreased to $122.7 million from $145.1 million, primarily reflecting a $17.6 million reduction in operating lease liabilities and the settlement of the convertible notes. Total stockholders’ equity was $8.0 million at June 30, 2026.

Fiscal 2027 Priorities
The Company’s operating priorities for fiscal 2027 are to raise utilization across its eleven-warehouse network, particularly the Georgia, Illinois, Texas, and Ontario, California facilities added or expanded over the past two fiscal years; to continue diversifying its customer base across e-commerce platforms and geographies, including Southeast Asia and Mexico, while growing higher-value warehousing relationships; to execute the cost-optimization plan described above; and to continue evaluating targeted investments in supply-chain technology and warehouse automation, including conveyor systems, as part of its effort to lower unit costs.

About Armlogi Holding Corp.
Armlogi Holding Corp., based in Walnut, CA, is a U.S.-based warehousing and logistics service provider offering a comprehensive suite of supply-chain solutions, including warehouse management and order fulfillment. The Company caters to cross-border e-commerce merchants seeking to establish U.S. market warehouses. With 11 warehouses totaling approximately 3.8 million square feet, the Company offers one-stop warehousing and logistics services. The Company’s warehouses are equipped with facilities and technology to handle and store large, bulky items. For more information, please visit www.armlogi.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, our representatives may from time to time make forward-looking statements, orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our ability to achieve or maintain profitability; our business prospects and opportunities; and the expected benefits of our operational initiatives, including raising warehouse utilization, executing our cost-optimization plan, diversifying our customer base, and evaluating investments in supply-chain technology and warehouse automation. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to raise utilization across our warehouse network and achieve the anticipated cost efficiencies; the concentration of our revenue from customers based in the People’s Republic of China and the impact of changes in U.S.-China trade relations, tariffs, and geopolitical conditions; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; changes in demand for our services; our dependence on third-party logistics service providers; and the going concern considerations described in our financial statements. These and other factors, including those described in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. Forward-looking statements speak only as of the date of this press release, and except as required by law, we undertake no obligation to update or revise any forward-looking statement publicly. The forward-looking events discussed in this press release and other statements made from time to time by our representatives or us may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions described above and in our SEC filings.

Company Contact:
info@armlogi.com

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

**Tables Follow**

 
ARMLOGI HOLDING CORP.
CONSOLIDATED BALANCE SHEETS
AS OF JUNE 30, 2026 AND 2025
(US$, except share data, or otherwise noted)
     
  June 30, 2026 June 30, 2025
  US$ US$
Assets    
Current assets    
Cash and cash equivalents 2,217,199   9,190,277
Accounts receivable and other receivables, net of credit loss allowance of $1,273,113 and $594,869 at June 30, 2026 and 2025, respectively 15,770,917   22,207,500
Other current assets, net of credit loss allowance of $266,953 and $nil 30,182   998,925
Prepaid expenses 926,375   1,375,646
Loan receivables, net of credit loss allowance of $453,449 and $nil 1,059,612   3,893,563
Total current assets 20,004,285   37,665,911
Non-current assets    
Restricted cash 4,325,148   4,387,550
Property and equipment, net 10,775,190   11,259,820
Intangible assets, net 13,148   54,627
Right-of-use assets – operating leases 93,905,576   115,361,185
Right-of-use assets – finance leases 1,092,157   745,547
Other non-current assets 631,934   739,555
Total assets 130,747,438   170,214,195
     
Liabilities and Stockholders’ Equity    
Current liabilities    
Accounts payable and accrued liabilities 9,994,669   9,604,783
Contract liabilities 515,997   939,097
Accrued payroll liabilities 441,503   283,150
Convertible notes —   5,292,749
Operating lease liabilities – current 34,028,979   29,280,907
Finance lease liabilities – current 641,734   386,327
Total current liabilities 45,622,882   45,787,013
Non-current liabilities    
Operating lease liabilities – non-current 76,606,696   98,939,552
Finance lease liabilities – non-current 502,442   397,692
Total liabilities 122,732,020   145,124,257
     
Stockholders’ equity    
Common stock, US$0.00001 par value, 100,000,000 shares authorized, 45,443,079 and 42,250,934 shares issued and outstanding as of June 30, 2026 and 2025, respectively 454   422
Additional paid-in capital 20,468,826   16,668,858
Retained earnings (accumulated deficit) (12,453,862 ) 8,420,658
Total stockholders’ equity 8,015,418   25,089,938
Total liabilities and stockholders’ equity 130,747,438   170,214,195

ARMLOGI HOLDING CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
FOR THE YEARS ENDED JUNE 30, 2026 AND 2025
(US$, except share data, or otherwise noted)
     
  Year Ended June 30, 2026 Year Ended June 30, 2025
  US$ US$
Revenue 185,835,053   190,408,258  
Costs of service 185,410,217   193,408,827  
Gross profit (loss) 424,836   (3,000,569 )
     
Operating costs and expenses:    
General and administrative 21,969,387   14,675,543  
Total operating costs and expenses 21,969,387   14,675,543  
     
Loss from operations (21,544,551 ) (17,676,112 )
     
Other (income) expenses:    
Other income, net (1,215,885 ) (2,714,344 )
Loss on debt extinguishment —   1,192,431  
Gain (loss) on disposal of assets (104,061 ) 43,625  
Finance costs 649,915   714,352  
Total other income (670,031 ) (763,936 )
     
Loss before provision for income taxes (20,874,520 ) (16,912,176 )
     
Current income tax recovery —   (26,954 )
Deferred income tax recovery —   (1,536,455 )
Total income tax recovery —   (1,563,409 )
Net loss (20,874,520 ) (15,348,767 )
Total comprehensive loss (20,874,520 ) (15,348,767 )
     
Basic and diluted net loss per share (0.47 ) (0.37 )
Weighted average number of shares of common stock – basic and diluted 44,691,736   41,808,909  

ARMLOGI HOLDING CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
FOR THE YEARS ENDED JUNE 30, 2026 AND 2025
(US$, except share data, or otherwise noted)
     
  Year Ended June 30, 2026 Year Ended June 30, 2025
  US$ US$
Cash flows from operating activities:    
Net loss (20,874,520 ) (15,348,767 )
Adjustments for items not affecting cash:    
Net (gain) loss from disposal of fixed assets (104,061 ) 43,625  
Depreciation of property and equipment and right-of-use finance lease assets 3,503,493   2,931,993  
Amortization 41,479   38,081  
Non-cash operating lease expense 3,891,672   7,536,058  
Current estimated credit loss 1,398,646   275,610  
Loss on debt extinguishment —   1,192,431  
Accretion of convertible note 527,251   617,845  
Deferred income taxes recovery —   (1,536,455 )
Interest income 20,503   (144,501 )
Changes in operating assets and liabilities:    
Accounts receivable and other receivables 5,758,337   2,981,935  
Other current assets 701,791   625,686  
Prepaid expenses 449,271   (246,211 )
Other non-current assets 107,621   (28,000 )
Accounts payable and accrued liabilities (269,504 ) 2,102,444  
Income tax payable —   (57,589 )
Contract liabilities (423,100 ) 662,634  
Accrued payroll liabilities 158,353   (122,100 )
Net changes in derecognized ROU and operating lease liability (20,847 ) (63,874 )
Net cash (used in) provided by operating activities (5,133,615 ) 1,460,845  
     
Cash flows from investing activities:    
Purchase of property and equipment (1,842,391 ) (2,889,928 )
Proceeds from disposal of property and equipment 191,161   48,000  
Loans extended to third parties (2,400,000 ) (1,000,000 )
Proceeds from loan repayments 4,760,000   2,036,705  
Net cash provided by (used in) investing activities 708,770   (1,805,223 )
     
Cash flows from financing activities:    
Lending to related parties —   (350,209 )
Repayments of finance lease liabilities (590,635 ) (360,443 )
Repayment of commitment payable —   (150,000 )
Repayment of convertible notes pursuant to SEPA (2,020,000 ) (3,260,000 )
Proceeds from convertible notes —   8,092,473  
Net cash (used in) provided by financing activities (2,610,635 ) 3,971,821  
     
Net (decrease) increase in cash and cash equivalents and restricted cash (7,035,480 ) 3,627,443  
Cash and cash equivalents and restricted cash, beginning of year 13,577,827   9,950,384  
Cash and cash equivalents and restricted cash, end of year 6,542,347   13,577,827  
     
Reconciliation of cash and cash equivalents and restricted cash:    
Cash and cash equivalents 2,217,199   9,190,277  
Restricted cash – non-current 4,325,148   4,387,550  
Total cash and cash equivalents and restricted cash shown in the consolidated balance sheets 6,542,347   13,577,827  
     
Supplemental disclosure of cash flows information:    
Cash paid for income tax —   (122,248 )
Cash paid for interest —   (96,507 )
     
Non-cash transactions:    
Increase (decrease) in right-of-use assets due to remeasurement of lease terms 63,896   (1,148,456 )
Right-of-use assets acquired in exchange for operating lease liabilities 4,605,476   27,857,474  
Right-of-use assets acquired in exchange for finance lease liabilities 950,792   819,155  
Shares issued to settle commitment fee —   250,000  
Shares issued upon conversion of convertible notes issued pursuant to SEPA 3,800,000   950,000  

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.